SOLVAY 1220
Generic Name: pancrelipase
Pill imprint SOLVAY 1220 has been identified as Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease.
Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy.
Creon 66,400 units amylase; 20,000 units lipase; 75,000 units protease is not subject to the Controlled Substances Act.
See also related documents.
Creon 20 Images
- Generic Name:
- pancrelipase
- Imprint:
-
SOLVAY
1220 - Strength:
- 66,400 units amylase; 20,000 units lipase; 75,000 units protease
- Color:
- Orange / Clear
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Solvay Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00032-1220
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3475 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Creon 20 resources
Search Again
